This is the second partnership announcement JDRF has made this week in a bid to develop wearable automated insulin supply programs for individuals with type 1 diabetes. On Wednesday, the charity introduced that they’ve teamed up with SFC Fluidics to develop a pioneering insulin supply system.
With this new partnership, JDRF will assist EOFlow Co. Ltd, a South Korean wearable medical system firm, to fund and run medical trials of a brand new insulin pump system.
The system will construct on the success of EOPatch, the corporate’s first product, which is marketed because the world’s lightest and most secure totally purposeful wearable, disposable insulin pump.
This new patch system consists of an insulin pump and a steady glucose sensor. It is run by a closed-loop program that regulates blood sugar ranges, and minimal consumer enter is required.
Whereas artificial pancreas programs may be fairly cumbersome, which may be problematic for children, EOFlow plans to construct their system so it’s small and light-weight sufficient for children’s use.
“Next-generation wearable designs that are smaller and employ user-centric design will remove barriers that prevent some people, especially small children, from using these life-saving and life-changing glucose management devices,” mentioned Jaime Giraldo, Ph.D., JDRF Research Scientist.
“Innovation in automated insulin delivery devices and artificial pancreas (AP) systems will help to significantly improve health and quality of life for people with T1D.”
EOFlow Chief Executive Officer Jesse Kim mentioned: “We are very excited that EOFlow is partnering with the world’s main non-public nonprofit funder of T1D analysis to speed up the event of this wearable automated insulin supply system.
“JDRF is a accomplice that believes in our imaginative and prescient of a small, sensible, totally purposeful artificial pancreas system that can be utilized by anybody with T1D to assist reside a fuller life.”